invest2 distinct publishers
Thyme Care raises Series E led by Morgan Health at 16 times revenue, with Humana and CVS Health Ventures joining
Morgan Health led a Series E of more than $125m that values Thyme Care above $2bn, roughly double its mark from under a year ago. The payers on the cap table are underwriting a savings number the company validated itself.
Reality
- Evidence42
- Adoption55
- Hype gap+32
- Incentives72